Skip to Content

FMX103 Approval Status

FDA Approved: No
Brand name: FMX103
Generic name: minocycline
Dosage form: Topical Foam
Company: Foamix Pharmaceuticals Ltd.
Treatment for: Rosacea

FMX103 is a topical minocycline foam formulation in development for the treatment of moderate-to-severe papulopustular rosacea.

Development Status and FDA Approval Process for FMX103

DateArticle
Oct 17, 2019Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea
Aug  5, 2019Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide